Business context and reporting period
WeShop Holdings Limited furnished this Form 6-K for September 2026, reporting that it entered into an Ordinary Shares Purchase Agreement and a related Registration Rights Agreement with Roth Principal Investments, LLC on September 9, 2026. This is a financing-agreement disclosure, not a report of operating or quarterly financial results.
Key financial and financing terms
- Potential proceeds: WeShop may, at its sole discretion, sell newly issued Class A ordinary shares for up to $25 million in aggregate. The company is not obligated to sell shares, and Roth’s commitment is subject to agreement conditions.
- Timing and duration: Purchases may begin only after the conditions are satisfied, including SEC effectiveness of the resale registration statement. The facility may be used for up to 36 months from commencement, subject to earlier termination provisions.
- Pricing: Market Open and Intraday Purchase prices are based on VWAP less 3%; Pre-Market and Post-Market prices are based on VWAP less 5%. Purchase notices, price thresholds, share limits, and other conditions apply.
- Fees and expenses: The $500,000 commitment fee equals 2% of the facility and is collected by withholding 10% of amounts otherwise payable to the company on purchases until paid in full. WeShop also agreed to pay $75,000 for Roth’s legal costs, reimburse up to $7,500 for specified recurring due-diligence legal costs, and reimburse up to $50,000 for the qualified independent underwriter’s fees and expenses.
- Use of proceeds: If shares are sold, the company currently expects to use net proceeds for working capital and general corporate purposes, including technology, member engagement, and its community ownership model.
- Operating metrics and liquidity: This filing does not provide revenue, profit, cash flow, margin, debt, cash balance, or other operating-performance figures; it does not quantify the company’s liquidity needs.
Material terms and potential changes
- The agreement permits multiple purchase types during different market periods. The company controls whether and when to make sales, subject to the agreement’s conditions.
- Nasdaq’s exchange cap generally limits issuance to 2,342,254 shares, or 19.99% of shares outstanding immediately before signing. Issuance above that limit requires shareholder approval, qualifying reliance on foreign-private-issuer home-country practice, or an average purchase price of at least $5.3475, as described in the agreement.
- Roth’s beneficial ownership from purchases is capped at 4.99% of outstanding shares.
- The agreements restrict certain variable-rate financings during the facility term, subject to exceptions and Roth’s prior written consent. Roth and specified related parties agree not to short or establish a net short position in the shares during the specified period.
Outlook, risks, contingencies, and unusual items
The facility is a potential source of equity capital, not guaranteed funding. The amount and timing of proceeds depend on the company’s elections, market conditions, share price, trading activity, purchase limits, registration effectiveness, and other conditions. Share issuance would dilute existing shareholders; the filing does not estimate the number of shares that may ultimately be issued or the resulting dilution.
Purchases are subject to a specified threshold price and delivery conditions; the threshold price and several detailed purchase limits are not stated in the filing text. The facility may terminate after the 36-month period, upon purchases reaching $25 million, loss of eligible-market listing, or specified bankruptcy-related events. The company may terminate after commencement with five trading days’ notice, subject to fee and expense provisions; termination within 90 days of signing may require payment of any remaining portion of the $500,000 fee.
Important facts for investors to verify
- Whether and when the resale registration statement becomes effective and the facility commences.
- The agreement’s full purchase limits, threshold price, settlement requirements, and the share-price and volume conditions applicable to each purchase type.
- How the exchange cap will be addressed if planned issuances approach 2,342,254 shares, and the potential dilution under different issuance scenarios.
- Actual proceeds after the 10% purchase-price withholding and other fees, reimbursements, and offering costs.
- Any subsequent share sales, amendments, termination, or updates to the company’s financing needs and intended use of proceeds.